BeStock  
Stocks › Biotechnology › KYMR

Kymera Therapeutics KYMR

US equityMarket cap rank #1426Biotechnology
$115.31 −$4.08 (-3.42%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $124.06 +7.59%
Open$117.89
Prev close$119.39
Day range$114.40 – $119.60
Volume1.28M
Market cap$9.84B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership111.7%+0.70 pts vs. prior quarter
Institutions holding376+25 vs. prior quarter
Insider trades (recent)14 buys / 36 sellsNet selling
ARK fund activity+17,659 sh2 recent transactions · last 2 Nov 2026
Short interest9.84% of floatDays to cover 10.5 · as of 30 Oct 2026
Short-sale volume share24.7%5-day average of daily volume

Short-sale volume as % of daily volume

14%21%29%37%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$18.04M (3 inflow days, 17 outflow days).

Net flow by order size, last 20 sessions

−$14.7MSuper−$3.4MBig−$3.9MMid+$11.9MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 50.8% of shares outstanding.

Largest holders

  • FMR14.72%
  • T. Rowe Price Group, Inc.10.39%
  • Baker Bros. Advisors LP10.14%
  • Avoro Capital Advisors LLC8.76%
  • BlackRock6.82%
  • BVF Partners L.P.4.54%
  • Wellington Management Group4.30%
  • Vanguard Capital Management, LLC3.57%

By investor type

  • Mutual Fund69.16%
  • Hedge Fund29.58%
  • VC/PE Fund8.31%
  • Public Company2.53%
  • Individual/Insider1.15%
  • Sovereign Wealth Fund0.90%
  • Private Company0.58%
  • Government Pension Fund0.26%

Reported short interest has fallen from 12.49% to 9.84% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
ARK Investment Management LLC Mutual Fund 2026/Q3 +111,599 0.1%
Fisher Investments Mutual Fund 2026/Q3 +310,487 0.4%
BlackRock Mutual Fund 2026/Q3 +287,206 6.8%
FMR Mutual Fund 2026/Q3 +219,665 14.7%
Morgan Stanley Public Company 2026/Q3 +164,349 0.4%
Morgan Stanley Investment Management Inc. Mutual Fund 2026/Q3 +164,349 0.4%
Fiera Capital Corporation Mutual Fund 2026/Q3 +118,933 0.1%
Vanguard Capital Management, LLC Mutual Fund 2026/Q3 +111,836 3.6%
T. Rowe Price Group, Inc. Mutual Fund 2026/Q3 +1,761,243 10.4%
Lord, Abbett & Co. LLC Mutual Fund 2026/Q3 +108,419 0.1%
Norges Bank Investment Management Sovereign Wealth Fund 2026/Q3 +740,703 0.9%
FMR Mutual Fund 2026/Q3 +649,485 14.9%
BlackRock Mutual Fund 2026/Q3 +477,334 6.7%
State Street Global Advisors Mutual Fund 2026/Q3 +347,459 3.3%
ClearBridge Investments, LLC Mutual Fund 2026/Q3 +347,221 0.4%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
30 Sep 2026 Nello Mainolfi Chief Executive Officer Derivative Exercise and Sale -30,000 $116.12 666,568
3 Sep 2026 Brian Adams Chief Legal Officer Open Market Disposition -6,371 $117.57 20,910
1 Sep 2026 Jeremy Chadwick Advisor Intent to Sell (Form 144) -10,879 $119.05 –
26 Jul 2026 Terence Rooney Chief Medical Officer Other Acquisition +38,000 – 38,000
26 Jul 2026 Terence Rooney Chief Medical Officer Other Derivative Acquisition +76,000 $110.05 76,000
6 Jul 2026 Nello Mainolfi Chief Executive Officer Derivative Exercise and Sale -50,000 $119.00 666,568
30 Jun 2026 Nello Mainolfi Chief Executive Officer Derivative Exercise and Sale -80,000 $116.56 666,568
30 Jun 2026 Noah Goodman Chief Business Officer Automatic Disposition -3,389 $114.29 454
29 Jun 2026 Bruce Jacobs Chief Financial Officer Automatic Disposition -15,731 $117.70 196,816
29 Jun 2026 Bruce Jacobs Chief Financial Officer Derivative Exercise and Sale -61,378 $115.82 196,816
25 Jun 2026 BVF Partners L.P. Private Disposition -1,630,658 $106.50 3,872,052
24 Jun 2026 Noah Goodman Chief Business Officer Derivative Exercise and Sale -5,000 $119.00 3,470
23 Jun 2026 John Michael Maraganore Independent Director Other Derivative Acquisition +6,068 $99.87 6,068
23 Jun 2026 Felix Baker Independent Chairperson Other Derivative Acquisition +12,136 $99.87 6,068
23 Jun 2026 BVF Partners L.P. Other Derivative Acquisition +6,068 $99.87 6,068
23 Jun 2026 Elena Ridloff Independent Director Other Derivative Acquisition +6,068 $99.87 6,068
23 Jun 2026 Bruce Booth Independent Director Other Derivative Acquisition +6,068 $99.87 6,068
23 Jun 2026 Jeffrey Albers Independent Director Other Derivative Acquisition +6,068 $99.87 6,068
23 Jun 2026 Pamela Esposito Independent Director Other Derivative Acquisition +6,068 $99.87 6,068
23 Jun 2026 Victor Sandor Independent Director Other Derivative Acquisition +6,068 $99.87 6,068

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 8,400,784 9.8% 10.5
15 Oct 2026 9,171,421 11.0% 10.0
30 Sep 2026 9,910,014 11.9% 12.0
15 Sep 2026 10,530,809 12.7% 16.1
31 Aug 2026 10,371,554 12.5% 16.8
14 Aug 2026 10,382,744 12.5% 13.9

Discussion

No comments yet — be the first to weigh in on KYMR.

Sign in to join the discussion.

Scroll to Top